Your browser doesn't support javascript.
loading
CD137 is a Useful Marker for Identifying CD4+ T Cell Responses to Mycobacterium tuberculosis.
Yan, Z-H; Zheng, X-F; Yi, L; Wang, J; Wang, X-J; Wei, P-J; Jia, H-Y; Zhou, L-J; Zhao, Y-L; Zhang, H-T.
Afiliación
  • Yan ZH; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Zheng XF; Department of Pathology, Capital Medical University, Beijing Chao-yang Hospital, Beijing, China.
  • Yi L; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Wang J; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Wang XJ; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Wei PJ; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Jia HY; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Zhou LJ; Department of Central Laboratory, Navy General Hospital, Beijing, China.
  • Zhao YL; Department of National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang HT; Department of Central Laboratory, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University and, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Scand J Immunol ; 85(5): 372-380, 2017 May.
Article en En | MEDLINE | ID: mdl-28218958
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Linfocitos T CD4-Positivos / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Tuberculosis Latente / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Immunol Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Linfocitos T CD4-Positivos / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Tuberculosis Latente / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Immunol Año: 2017 Tipo del documento: Article País de afiliación: China